Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells
被引:182
作者:
Park, JW
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Park, JW
论文数: 引用数:
h-index:
机构:
Choi, YJ
论文数: 引用数:
h-index:
机构:
Jang, MA
论文数: 引用数:
h-index:
机构:
Lee, YS
Jun, DY
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Jun, DY
Suh, SI
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Suh, SI
Baek, WK
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Baek, WK
Suh, MH
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Suh, MH
Jin, IN
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Jin, IN
Kwon, TK
论文数: 0引用数: 0
h-index: 0
机构:Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
Kwon, TK
机构:
[1] Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea
[2] Keimyung Univ, Sch Med, Dept Microbiol, Taegu 700712, South Korea
[3] Kyungpook Natl Univ, Coll Nat Sci, Dept Microbiol, Taegu 702701, South Korea
resveratrol;
cell cycle;
cyclin;
cancer chemopreventive agent;
D O I:
10.1016/S0304-3835(00)00658-3
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 [肿瘤学];
摘要:
Resveratrol, a natural product derived from grapes, has been shown to prevent carcinogenesis in murine models. We report here that resveratrol induces antiproliferation and arrests the S phase in human histiocytic lymphoma U937 cells. Resveratrol induces arrest in the S phase at low concentrations (30-60 muM), but high concentrations do not induce S phase accumulation in U937 cells. Removal of resveratrol from the culture medium stimulates U937 cells to reenter the cell cycle synchronously, as judged by the expression patterns of cyclin E, A and by fluorescent activated cell sorting analysis. These data demonstrate that resveratrol causes S phase arrest and reversible cell cycle arrest. Thus, resveratrol provides an important new cell cycle blocker as well as a cancer chemopreventive agent. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Fauconneau, B
;
WaffoTeguo, P
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
WaffoTeguo, P
;
Huguet, F
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Huguet, F
;
Barrier, L
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Barrier, L
;
Decendit, A
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Decendit, A
;
Merillon, JM
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Fauconneau, B
;
WaffoTeguo, P
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
WaffoTeguo, P
;
Huguet, F
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Huguet, F
;
Barrier, L
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Barrier, L
;
Decendit, A
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE
Decendit, A
;
Merillon, JM
论文数: 0引用数: 0
h-index: 0
机构:
FAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCEFAC PHARM, STUDY GRP NAT SUBST THERAPEUT INTEREST, EA 491, BORDEAUX, FRANCE